Oxford Finance Corporation

Alexandria, Virginia, USA

Oxford Finance Corporation is a specialty finance firm that provides senior secured loans and tailored credit solutions to companies globally. The company focuses on several sectors, including life sciences, healthcare services, and healthtech.

Shareable draft

Check out Oxford Finance Corporation on @MedStartr Today Oxford Finance Corporation is a specialty finance firm that provides senior secured loans and tailored credit solutions to companies globally. The company focuses on several sectors, including life sciences, healthcare services, and healthtech. #Biopharmaceuticals #HealthcareInfrastructure #MedMo #MedStartrVentures

https://www.medstartr.ai/s/b_Due4CWdLk

Get Involved in Oxford Finance Corporation

How We Help

Problem Statement

Companies in the healthcare and life sciences sectors often require specialized, flexible financing solutions for growth, working capital, acquisitions, or restructuring, which traditional lenders may not adequately provide. Oxford Finance addresses this need by offering tailored senior secured loans.

Key Differentiators

Specializes in providing capital to the life sciences and healthcare services sectors globally. Has originated over $14 billion in loans to more than 700 companies worldwide. Offers a variety of flexible financing solutions for growth initiatives, working capital, acquisitions, refinancing existing debt, restructuring, and recapitalization.

Clinical Focus

Healthcare and life sciences sectors

Target Customers

Companies, primarily within the healthcare and life sciences sectors, including healthtech and SaaS borrowers.

Company Info

Business Model: Other
Founded: 2002
Total Funding: Only accessible to MedStartr community members. Join now
Only accessible to MedStartr community members.
Join now
Website: www.oxfordfinance.com

Disease Areas

Biopharmaceuticals

Technologies

SaaS

🌐Website

MedStartr Engagement Score

Too Big!

The MedStartr Index is a reflection of how the crowds that come to MedStartr everyday to find healthcare innovations reacted. Calculated by our AI agent Fyggy based on algorithms we have been building since 2012 and over 100 different factors, the math is proprietary and complex. Suffice to say, it has been found to be highly correlative with early stage company growth. What you see here is the public version. To learn more or to get deeper access to our predictive data on startup success for your fund or company, click here.

Comments

Comments from new members are shown once the company's team has approved them. Please follow the community rules.

Be the first to comment.

What do you think of Oxford Finance Corporation?

A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.

Clinical Benefit Potential

The potential for a project to have a large and significant impact on medical care, treatment, or prevention.

Feasibility

The likelihood that this will provide benefit for patients / care givers and that the founders can execute on their vision and plan.

Innovativeness

The distinguishing features, concept, or technology that differentiates the entry compared to others that already exist and are in widespread use.

Fundability

The reviewers' beliefs that the idea is fundable or can make it to sustainability without outside investment.

Scalability

Some great ideas are destined to failure because they are too complex or too expensive. The reviewer should consider the likelihood that a project as explained, or perhaps with some tweaks, could possibly become a worldwide solution within a reasonable time frame.

Presentation Quality

How well the team presented the idea.

Submit anonymously — my name won't be shown to the team or on this profile

Your scores and comments are shown with your review on this company's profile.